Navigation Links
Gene 'Switch' May Help Drive Excess Fluid in Lungs

Finding could lead to treatments for bronchitis, asthma, researchers say

TUESDAY, Sept. 15 (HealthDay News) -- The discovery of a genetic switch that makes mucus production go into overdrive could potentially lead to better treatments for chronic lung ailments, a new study says.

Excessive mucus production in the lungs can cause illness or death from asthma, cystic fibrosis, bronchitis, common colds and other illnesses. From a biological perspective, it's unclear why the body creates dangerous levels of mucus, the researchers noted in the Sept. 14 online issue of the Journal of Clinical Investigation.

"Everyone has had a stuffed-up nose and cough after two or three weeks of a bad cold, and most over-the-counter cold medications deal with mucus," said Dr. Jeffrey Whitsett, lead author of the study and the head of neonatology, perinatal and pulmonary biology at Cincinnati Children's Hospital Medical Center, in a hospital news release. "We still don't have effective therapies for removing excess mucus, whether it's someone with a cold or chronic lung disease. That's why we still tap on the chests of kids with cystic fibrosis to try and clear it."

In the study, the researchers found that lung cells convert from good cells to bad -- creating mucus in the process. But if a genetic switch is blocked, they can change back to good cells.

However, Whitsett said it will be several years before researchers can figure out how to develop a new treatment based on the results.

More information

Learn more about cystic fibrosis from the Nemours Foundation.

-- Randy Dotinga

SOURCE: Cincinnati Children's Hospital Medical Center, news release, Sept. 14, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Scientists Turn Off Obesity Switch in Mice
2. AUDIO from Medialink and Forest Laboratories: Dangers of Switching Medications
3. Switch to digital mammography leads to increased cancer detection rates
4. People Across the Country are Making The Switch!
5. Scientists locate disease switches
6. For Treatment of Dyslipidemia, Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials
7. Herleys Israeli Subsidiary, GMI Eyal, is Selected to Provide Complex Microwave Switch Assemblies for a U.S. Customer
8. The Female Health Company Switches to the NASDAQ Stock Market
9. National Pharmacy Omnicare Pays 'Unusual' Settlement to Resolve Charges of Generic Drug Switching in Delaware Nursing Homes, Resulting From 'Qui Tam' Lawsuit
10. UCSF creates fast, affordable tool for finding gene on-off switches
11. Schering-Plough Flips the Switch on 1.7 MW Rooftop Solar Panel System, One of the Largest in N.J., North America
Post Your Comments:
Related Image:
Gene 'Switch' May Help Drive Excess Fluid in Lungs 
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic ... addition to the devices for sale in the United States. Clarity is a ... 1064 nm Nd:YAG lasers, into a single platform that is easy to own and ...
(Date:12/1/2015)... ... ... With FCPX Overlay: Grit , users can apply a grit effect ... truly endless, all with a click of a mouse. Each user has full control ... of field and more, all within Final Cut Pro X. , With FCPX Overlay: ...
(Date:11/30/2015)... India (PRWEB) , ... November 30, 2015 , ... ... dental search engine optimization companies, announced today that it has officially launched a ... Third Molar SEO, explained that his company’s new website clearly outlines the benefits ...
(Date:11/30/2015)... ... 2015 , ... The National Association of Professional Women (NAPW) honors ... Year Circle. She is recognized with this prestigious distinction for leadership in estate sales ... more than 850,000 members and over 200 operating Local Chapters. , “I’m pleased to ...
(Date:11/30/2015)... ... November 30, 2015 , ... Until now, the St. ... in the MOMS (Management of Myelomeningocele Study) trial. One of these exclusion criteria was ... a BMI of 18.5 to 24.9 is considered normal, 25 - 29.9 is overweight ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  InCarda ... the development and commercialization of therapies for cardiovascular conditions ... established a subsidiary business in Australia ... clinical trial in Australia in ... with leading investigators and medical centers in ...
(Date:12/1/2015)... and TELTOW, Germany , December ... (SMI) , a leading global manufacturer of eye and ... has included SMI remote eye trackers as a ... healthcare providers assess concussions, eye sight, and medical and ... -oem technology is part of SMI,s mass-market-ready eye tracking ...
(Date:12/1/2015)... -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced ... 2016 as the ex-distribution date for Ampio,s previously announced ... Stock of Aytu BioScience, Inc. As announced, Ampio will ... every five (5) shares of Ampio Common Stock owned ... date will be January 4, 2016. ...
Breaking Medicine Technology: